Lieberman Speaks in Dubai at Three International Conferences

Pediatric nephrology chief shares expertise on aHUS

Kenneth Lieberman, M.D., chief of Pediatric Nephrology at Joseph M. Sanzari Children’s Hospital, presented at three international conferences in Dubai in March 2023, lecturing on atypical Hemolytic Uremic Syndrome (aHUS).

Dr. Lieberman presented “New Approach of aHUS Management” at the 3rd Annual Kidney Replacement Therapy and Critical Care Nephrology Conference of the Saudi Society of Nephrology & Transplantation. He also spoke on aHUS at the 7th Annual International Pediatric Summit. Finally, he delivered the keynote for a meeting focused on “Challenges in aHUS Diagnosis and New Management Approach,” hosted by Biologix. Dr. Lieberman’s presentation was entitled “DIfferential Diagnosis of TMA and CAC.”

“Presentations like these allow us to raise awareness internationally for this rare but serious disease,” said Dr. Lieberman. “Early diagnosis of aHUS may allow for improved disease management.”

aHUS is a chronic and life-threatening disease that causes tiny blood clots to form in the blood vessels, blocking blood flow to important organs, especially the kidneys. It can cause kidney failure, heart disease, and other serious health problems.

Dr. Lieberman, a pioneer in the use of genetics to diagnose kidney disease, and an expert in the treatment of many kidney conditions, is a researcher and clinician who has lectured around the world, including at meetings of the Congress of the International Pediatric Nephrology Association. Last year, he served on a renal genetics roundtable at a forum sponsored by the National Kidney Foundation. In 2019, he was designated a nephrotic syndrome specialist by NephCure International.

Learn more about our advancements in pediatric nephrology.